CapitalCell

Capital Cell is the first platform in Europe for financing biotech startups through crowdfunding.

Mixing VC deals and crowdfunding we are building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science In their crowdinvesting marketplace for health & biotech, global investors of any size can invest in non-listed companies via equity-crowdfunding, being informed about scientific and financial characteristics of every project.

Spanish law does not allow campaigns of more than 2 million euros (or 5 million if only accredited investors participate), so this is usually the maximum limit for rounds.

Regarding the target declared on the website, rounds must reach a minimum of 90% in order to be declared successful, and in no case may they exceed 125% of the announced target. This means that once 100% of the target has been reached, campaigns can continue to attract investors until they reach the maximum limit of 125%.

You can invest a minimum of 100€ and a maximum of 1000€ most of the times. 

Applicants willing to submit their pitch decks can do it by following this link.

Portfolio: Laminar Pharma, Vytrus, Oncostellae, Nuubo.